Current Search Criteria:
Intervention: CYD Dengue Vaccine Serotypes 1, 2, 3, and 4
Found 12 matching trials
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
PHASE3The purpose of this study was to evaluate the safety and immunogenicity of ...
Location
Multiple Locations
Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India
PHASE2The aim of this study is to evaluate the immunogenicity and safety of the C...
Location
Multiple Locations
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
PHASE3The aim of the study was to assess the efficacy of Sanofi Pasteur's CYD den...
Location
Multiple Locations
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects
PHASE2This trial evaluated the use of a tetravalent vaccine against dengue.
Prim...
Location
Sanofi Pasteur Investigational Site
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America
PHASE2The purpose of this study is to generate immunogenicity and safety data in ...
Location
Multiple Locations
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
PHASE2The aim of this study was to evaluate the administration of CYD dengue vacc...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virusYellow Fever A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
PHASE2The purpose of this study is to investigate the potential for co-administra...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virusOKAVAX®:Attenuated live varicella-zoster virus and AVAXIM® 80U: Hepatitis A virus VaccinesLive, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and Childhood vaccinesLive, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and NaCl (Placebo) Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
PHASE3The aim of the study was to assess whether the second CYD dengue vaccinatio...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virusDTaP IPV//Hib vaccinePlaceboMeasles, mumps, and rubella vaccinePneumococcal vaccineLive, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virusDTaP IPV//Hib vaccinePlaceboMeasles, mumps, and rubella vaccinePneumococcal vaccine Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
PHASE3The aim of the trial was to assess the efficacy of the CYD dengue vaccine i...
Location
Multiple Locations
Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia
PHASE3The purpose of this study was to demonstrate that different CYD dengue vacc...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virusLive, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virusPlacebo: NaCl 0.9%